Narra S. Devi

6.9k citations

20 papers · 1.1k · h-index 16

Impact in

Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
Immunology and Allergy top 10%

Papers in

Molecular Biology 12
- Epigenetics and DNA Methylation 3
- ATP Synthase and ATPases Research 3
- Angiogenesis and VEGF in Cancer 2
- Histone Deacetylase Inhibitors Research 2
- Metabolism, Diabetes, and Cancer 2
Cancer Research 11
- Cancer, Hypoxia, and Metabolism 11

Co-authors: Erwin G. Van Meir (20 shared papers)Daniel J. Brat (4 shared papers)Balveen Kaur (3 shared papers)Mourad Tighiouart (2 shared papers)Tatiana A. Chernova (1 shared paper)Keith D. Wilkinson (1 shared paper)Kenneth L. Friedrich (1 shared paper)Karen Ventii (1 shared paper)
Journals: Clinical Cancer Research (5 papers)Cancer Research (4 papers)Oncogene (3 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)Journal of Medicinal Chemistry (2 papers)
Partner nations: United States China Germany

In The Last Decade

Narra S. Devi

20 papers receiving 1.1k citations

Peers

Countries citing papers authored by Narra S. Devi

Since Specialization

Citations

This map shows the geographic impact of Narra S. Devi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Narra S. Devi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Narra S. Devi more than expected).

Fields of papers citing papers by Narra S. Devi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Narra S. Devi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Narra S. Devi. The network helps show where Narra S. Devi may publish in the future.

Co-authors

The 25 scholars most cited alongside Narra S. Devi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Narra S. Devi Line = papers co-authored together Narra S. Devi links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	BRCA1-Associated Protein-1 Is a Tumor Suppressor that Requires Deubiquitinating Activity and Nuclear Localization Cancer Research ·Karen Ventii, Narra S. Devi, Kenneth L. Friedrich, Tatiana A. Chernova, Mourad Tighiouart, Erwin G. Van Meir, Keith D. Wilkinson	2008	268
2	Vasculostatin, a proteolytic fragment of Brain Angiogenesis Inhibitor 1, is an antiangiogenic and antitumorigenic factor Oncogene ·Balveen Kaur, Daniel J. Brat, Narra S. Devi, Erwin G. Van Meir	2005	147
3	Vasculostatin Inhibits Intracranial Glioma Growth and Negatively Regulates In vivo Angiogenesis through a CD36-Dependent Mechanism Cancer Research ·Balveen Kaur, Sarah M. Cork, Eric M. Sandberg, Narra S. Devi, Zhaobin Zhang, Philip A. Klenotic, Maria Febbraio, Hyunsuk Shim, Hui Mao, Carol Tucker‐Burden, Roy L. Silverstein, Daniel J. Brat, Jeffrey J. Olson, Erwin G. Van Meir	2009	101
4	Targeted Cancer Gene Therapy Using a Hypoxia Inducible Factor–Dependent Oncolytic Adenovirus Armed with Interleukin-4 Cancer Research ·Dawn E. Post, Eric M. Sandberg, Michele Kyle, Narra S. Devi, Daniel J. Brat, Zhiheng Xu, Mourad Tighiouart, Erwin G. Van Meir	2007	95
5	Arylsulfonamide KCN1 Inhibits In Vivo Glioma Growth and Interferes with HIF Signaling by Disrupting HIF-1α Interaction with Cofactors p300/CBP Clinical Cancer Research ·Shaoman Yin, Štefan Kaluz, Narra S. Devi, Adnan Abdul Jabbar, Rita G. de Noronha, Ji-Young Mun, Zhaobin Zhang, Purushotham R. Boreddy, Wei Wang, Zhibo Wang, Thomas J. Abbruscato, Zhengjia Chen, Jeffrey J. Olson, Ruiwen Zhang, Mark M. Goodman, Kyriaco C. Nicolaou, Erwin G. Van Meir	2012	73
6	BAI1 Suppresses Medulloblastoma Formation by Protecting p53 from Mdm2-Mediated Degradation Cancer Cell ·Dan Zhu, Satoru Osuka, Zhaobin Zhang, Zachery R. Reichert, Liquan Yang, Yonehiro Kanemura, Ying Jiang, Shuo You, Hanwen Zhang, Narra S. Devi, Debanjan Bhattacharya, Shingo Takano, G. Yancey Gillespie, Tobey J. MacDonald, Chalet Tan, Ryo Nishikawa, William G. Nelson, Jeffrey J. Olson, Erwin G. Van Meir	2018	58
7	Selective Detection of the D-enantiomer of 2-Hydroxyglutarate in the CSF of Glioma Patients with Mutated Isocitrate Dehydrogenase Clinical Cancer Research ·Juliya Kalinina, Jun Young Ahn, Narra S. Devi, Liya Wang, Yuancheng Li, Jeffrey J. Olson, Michael Glantz, Thomas W. Smith, Ella L. Kim, Alf Giese, Randy L. Jensen, Clark C. Chen, Bob S. Carter, Hui Mao, Miao He, Erwin G. Van Meir	2016	55
8	Arylsulfonamide 64B Inhibits Hypoxia/HIF-Induced Expression of c-Met and CXCR4 and Reduces Primary Tumor Growth and Metastasis of Uveal Melanoma Clinical Cancer Research ·Lei Dong, Shuo You, Qing Zhang, Satoru Osuka, Narra S. Devi, Štefan Kaluz, Jalisa H. Ferguson, Hua Yang, Guoliang Chen, Binghe Wang, Hans E. Grossniklaus, Erwin G. Van Meir	2018	54
9	Cancer Therapy with a Replicating Oncolytic Adenovirus Targeting the Hypoxic Microenvironment of Tumors Clinical Cancer Research ·Dawn E. Post, Narra S. Devi, Zhenchao Li, Daniel J. Brat, Balveen Kaur, Ainsley Nicholson, Jeffrey J. Olson, Zhaobin Zhang, Erwin G. Van Meir	2004	53
10	Design and in Vitro Activities of N-Alkyl-N-[(8-R-2,2-dimethyl-2H-chromen-6-yl)methyl]heteroarylsulfonamides, Novel, Small-Molecule Hypoxia Inducible Factor-1 Pathway Inhibitors and Anticancer Agents Journal of Medicinal Chemistry ·Ji-Young Mun, Adnan Abdul Jabbar, Narra S. Devi, Shaoman Yin, Yingzhe Wang, Chalet Tan, Deborah G. Culver, James P. Snyder, Erwin G. Van Meir, Mark M. Goodman	2012	49
11	Design and Synthesis of Novel Small-Molecule Inhibitors of the Hypoxia Inducible Factor Pathway Journal of Medicinal Chemistry ·Suazette Reid Mooring, Hui Jin, Narra S. Devi, Adnan Abdul Jabbar, Štefan Kaluz, Yuan Liu, Erwin G. Van Meir, Binghe Wang	2011	43
12	EZH2 targeting reduces medulloblastoma growth through epigenetic reactivation of the BAI1/p53 tumor suppressor pathway Oncogene ·Hanwen Zhang, Dan Zhu, Zhaobin Zhang, Štefan Kaluz, Bing Yu, Narra S. Devi, Jeffrey J. Olson, Erwin G. Van Meir	2019	31
13	Structure–activity relationship of 2,2-dimethyl-2H-chromene based arylsulfonamide analogs of 3,4-dimethoxy-N-[(2,2-dimethyl-2H-chromen-6-yl)methyl]-N-phenylbenzenesulfonamide, a novel small molecule hypoxia inducible factor-1 (HIF-1) pathway inhibitor and anti-cancer agent Bioorganic & Medicinal Chemistry ·Ji-Young Mun, Adnan Abdul Jabbar, Narra S. Devi, Yuan Liu, Erwin G. Van Meir, Mark M. Goodman	2012	30
14	Sulfonamides as a new scaffold for hypoxia inducible factor pathway inhibitors Bioorganic & Medicinal Chemistry Letters ·Chalet Tan, Rita G. de Noronha, Narra S. Devi, Adnan Abdul Jabbar, Štefan Kaluz, Yuan Liu, Suazette Reid Mooring, K. C. Nicolaou, Binghe Wang, Erwin G. Van Meir	2011	30
15	Targeting HIF-activated collagen prolyl 4-hydroxylase expression disrupts collagen deposition and blocks primary and metastatic uveal melanoma growth Oncogene ·Štefan Kaluz, Qing Zhang, Yuki Kuranaga, Hua Yang, Satoru Osuka, Debanjan Bhattacharya, Narra S. Devi, Ji-Young Mun, Wei Wang, Ruiwen Zhang, Mark M. Goodman, Hans E. Grossniklaus, Erwin G. Van Meir	2021	28
16	Binding Model for the Interaction of Anticancer Arylsulfonamides with the p300 Transcription Cofactor ACS Medicinal Chemistry Letters ·Qi Shi, Shaoman Yin, Štefan Kaluz, Nanting Ni, Narra S. Devi, Ji-Young Mun, Danzhu Wang, Krishna Damera, Weixuan Chen, Sarah Burroughs, Suazette Reid Mooring, Mark M. Goodman, Erwin G. Van Meir, Binghe Wang, James P. Snyder	2012	15
17	A Chimeric Signal Peptide–Galectin-3 Conjugate Induces Glycosylation-Dependent Cancer Cell–Specific Apoptosis Clinical Cancer Research ·Sok-Hyong Lee, Fatima Rehman, Kari C. Tyler, Bing Yu, Zhaobin Zhang, Satoru Osuka, Abdessamad Zerrouqi, Milota Kaluzová, Costas G. Hadjipanayis, Richard D. Cummings, Jeffrey J. Olson, Narra S. Devi, Erwin G. Van Meir	2020	8
18	Examining the structure-activity relationship of benzopyran-based inhibitors of the hypoxia inducible factor-1 pathway Bioorganic & Medicinal Chemistry Letters ·Jalisa H. Ferguson, Zeus A. De los Santos, Narra S. Devi, Erwin G. Van Meir, Sarah K. Zingales, Binghe Wang	2017	8
19	Targeting Integrin α3 Blocks β1 Maturation, Triggers Endoplasmic Reticulum Stress, and Sensitizes Glioblastoma Cells to TRAIL-Mediated Apoptosis Cells ·Yuki Kuranaga, Bing Yu, Satoru Osuka, Hanwen Zhang, Narra S. Devi, Sejong Bae, Erwin G. Van Meir	2024	3
20	Abstract B17: ADGRB3 is a novel tumor suppressor epigenetically silenced in WNT medulloblastoma Cancer Research ·Debanjan Bhattacharya, Dan Zhu, Narra S. Devi, Erwin G. Van Meir	2018	1

About Narra S. Devi

Narra S. Devi is a scholar working on Molecular Biology, Cancer Research, Genetics, Oncology and Genetics, having authored 20 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (11 papers), Epigenetics and DNA Methylation (3 papers), Cancer-related Molecular Pathways (3 papers), ATP Synthase and ATPases Research (3 papers), Genetics and Neurodevelopmental Disorders (2 papers), Angiogenesis and VEGF in Cancer (2 papers), Histone Deacetylase Inhibitors Research (2 papers) and Metabolism, Diabetes, and Cancer (2 papers). The work is most often cited by research in Cancer Research (306 citations), Immunology and Allergy (78 citations), Ophthalmology (102 citations), Oncology (251 citations) and Molecular Biology (685 citations). Narra S. Devi has collaborated with scholars based in United States, China and Germany. Frequent co-authors include Erwin G. Van Meir, Daniel J. Brat, Balveen Kaur, Mourad Tighiouart, Tatiana A. Chernova, Keith D. Wilkinson, Kenneth L. Friedrich, Karen Ventii, Zhaobin Zhang and Štefan Kaluz. Their work appears in journals such as Clinical Cancer Research, Cancer Research, Oncogene, Bioorganic & Medicinal Chemistry Letters and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Narra S. Devi

Impact in

Papers in i

In The Last Decade

Narra S. Devi

Peers

Countries citing papers authored by Narra S. Devi

Fields of papers citing papers by Narra S. Devi

All Works

About Narra S. Devi

Explore authors with similar magnitude of impact

Papers in